Brind.
  1. Tronox faced declining revenue and earnings estimates, leading to consensus recommendations from brokerage firms on July 29, 2025.

The Aristotle Capital Strategy sold Tronox due to increased uncertainty and noted the stock's underperformance against the Russell 2000 Index.

1 report, 1 independent Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The Aristotle Capital Strategy sold Tronox due to increased uncertainty and noted the stock's underperformance against the Russell 2000 Index.

Who's involved

What this event is mainly about
Tronox

Keep exploring

Part of

Tronox faced declining revenue and earnings estimates, leading to consensus recommendations from brokerage firms on July 29, 2025. All 1 developments

The entities involved

  • Tronox

    American chemical company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Insider MonkeyAristotle Small Cap Equity Strategy Sold Tronox (TROX) due to Increased Uncertainty Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Strategy” second quarter 2025